Kestra Medical Technologies Ltd (KMTS) Annual Balance Sheets

Annual · GAAP · USD millions
Access KMTS quarterly Balance Sheets →
Balance sheet data covering Kestra Medical Technologies Ltd– offers a view into how Apr 30 2026's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Apr 30 2026)
(Apr 30 2024)
Assets
Cash & cash equivalent262.20
Marketable Securities96.72
Cash & Short-term Investments358.00
Accounts receivable14.54
Other Receivables0.00
Prepaid Expense And Other Assets Current4.68
Total Current Assets222.36
Equipment/Property/Plant Net90.52
Long-term investments65.77
Deposits Assets, Noncurrent AS1.76
Tax Assets, Noncurrent11.68
Total Assets358.47
Liabilities
Accounts Payable, Current AC27.30
Accrued Liabilities, Current AC23.05
Other Liabilities, Current0.03
Total Current Liabilities50.37
Long-term debt42.65
Total Long-term Debt42.65
Accrued Income Taxes, Noncurrent11.99
Total Liabilities98.81
Stockholders' Equity
Common Stock Value58.38
Additional Paid In Capital Common Stock853.35
Retained Earnings / Accumulated Deficit-651.86
Accumulated Other Comprehensive Income-0.22
Defined Benefit Plan and Other1.37
Other Equity-0.22
Common Stockholder's Equity259.66
Non-controlling interests & other0.00
Total Stockholder's Equity259.66
Liabilities & Stockholder's Equity358.47
4 historic quarters locked

Sign in to unlock the full Kestra Medical Technologies Ltd balance sheet history.

About Kestra Medical Technologies Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-303397

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.